Status: current, Defined. Date: 31-Mar 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4544091000168114 | Pavtide MDI 50/25 (fluticasone propionate 50 microgram / 1 actuation + salmeterol 25 microgram / 1 actuation) inhalation, 120 actuations, aerosol can (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4544101000168116 | Pavtide MDI 50/25 inhalation, 120 actuations, aerosol can | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Pavtide MDI 50/25 inhalation, 120 actuations, aerosol can | Is a | Pavtide MDI 50/25 inhalation, 120 actuations | true | Inferred relationship | Some | ||
| Pavtide MDI 50/25 inhalation, 120 actuations, aerosol can | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Pavtide MDI 50/25 inhalation, 120 actuations, aerosol can | has container type | aerosol can | true | Inferred relationship | Some | ||
| Pavtide MDI 50/25 inhalation, 120 actuations, aerosol can | has TP | Pavtide MDI 50/25 | true | Inferred relationship | Some | ||
| Pavtide MDI 50/25 inhalation, 120 actuations, aerosol can | has TPUU | Pavtide MDI 50/25 inhalation, actuation | true | Inferred relationship | Some | 1563815762 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR